论文部分内容阅读
目的探讨围绝经期子宫肌瘤患者进行期待疗法的临床依据、适应证及临床效果。方法对符合入选条件的30例围绝经期子宫肌瘤患者采用期待疗法,并进行定期随访。结果30例患者中有2例失访,余28例随访时间18~48个月,无一例肌瘤变性。其中终止期待疗法6例,均开腹行子宫全切除术。其余患者继续随访,无肌瘤增大趋势,无新增症状。结论围绝经期子宫肌瘤患者进行期待疗法避免了手术带来的痛苦、并发症、心理障碍和药物治疗所产生的不良反应。但应用中应严格掌握适应证,严密随访。
Objective To investigate the clinical basis, indications and clinical effects of expectant therapy in patients with uterine fibroids during menopause. Methods 30 cases of menopausal uterine fibroids who met the inclusion criteria were treated with expectant therapy and followed up regularly. Results Two out of 30 patients were lost to follow-up. The remaining 28 patients were followed up for 18 to 48 months without any fibroid degeneration. Among them, 6 cases were expectantly terminated and all underwent hysterectomy. The remaining patients were followed up, no fibroids increased trend, no new symptoms. Conclusions Perioperative treatment of patients with uterine fibroids in menopause avoids the pain, complications, psychological disorders and adverse reactions caused by medical treatment. However, applications should be strictly controlled indications, close follow-up.